MDxHealth (MDXH) Capital Expenditures (2021 - 2026)

MDxHealth has disclosed Capital Expenditures across 5 years of filings, most recently posting -$362000.0 for Q1 2026.

• Capital Expenditures for Q1 2026 came in at -$362000.0, up 23.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 343.73% YoY), and the FY2025 annual result was $1.2 million, down 2.61% from the prior year.
• Capital Expenditures came in at -$362000.0 for Q1 2026 at MDxHealth, up from -$1.1 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $2.2 million in Q4 2024 to a low of -$1.1 million in Q3 2025.
• The 4-year median for Capital Expenditures is -$419000.0 (2025), against an average of -$216500.0.
• Across the five-year window, Capital Expenditures sank 425.24% in 2025 and advanced 23.95% in 2026, its largest moves.
• MDxHealth's Capital Expenditures stood at -$357000.0 in 2022, then surged by 711.76% to $2.2 million in 2024, then tumbled by 150.5% to -$1.1 million in 2025, then jumped by 67.18% to -$362000.0 in 2026.
• The last three Capital Expenditures figures came in at -$362000.0 (Q1 2026), -$1.1 million (Q3 2025), and -$840000.0 (Q2 2025), per Business Quant data.